Literature DB >> 9204981

Human A1, a Bcl-2-related gene, is induced in leukemic cells by cytokines as well as differentiating factors.

J S Moreb1, M Schweder.   

Abstract

Based on previously published observations regarding the protective effects of interleukin-1 (IL-1) and tumor necrosis factor alpha (TNF alpha) against gamma radiation, alkylating agents and ultraviolet radiation, we hypothesized that the protection against such DNA damaging treatments can be the result of a 'stress'-like response induced by these cytokines and mediated by early response cellular gene(s). By applying the mRNA differential display to RNA obtained from A549 lung carcinoma cell line that was incubated with 50 ng/ml IL-1 for 0, 1, 2, and 6 h, we identified several cDNA fragments that correspond to genes regulated by IL-1. The full length cDNA for one fragment was obtained using 5'RACE, cloned, sequenced, and found to be homologous to human A1, a Bcl-2-related gene. In this study, we report that the expression of human A1 is either absent or present at low levels in leukemic cells, while it is expressed in human bone marrow cells and abundant in peripheral blood progenitors. It is induced by IL-1 and TNF alpha in A549 lung carcinoma, bone marrow, and certain leukemic cells. A1 is also induced in leukemic cells during granulocytic or macrophage but not erythroid differentiation. In conclusion, this is the first demonstration that A1 is inducible by cytokines in human bone marrow and certain tumor cells as well as myeloid differentiation in leukemic cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9204981     DOI: 10.1038/sj.leu.2400719

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  8 in total

1.  Acute myeloid leukemia is associated with retroviral gene transfer to hematopoietic progenitor cells in a rhesus macaque.

Authors:  Ruth Seggewiss; Stefania Pittaluga; Rima L Adler; F Javier Guenaga; Cole Ferguson; Ingo H Pilz; Byoung Ryu; Brian P Sorrentino; W Scott Young; Robert E Donahue; Christof von Kalle; Arthur W Nienhuis; Cynthia E Dunbar
Journal:  Blood       Date:  2006-01-26       Impact factor: 22.113

2.  NF-kappa B-dependent assembly of an enhanceosome-like complex on the promoter region of apoptosis inhibitor Bfl-1/A1.

Authors:  Leonard C Edelstein; Lynn Lagos; Matthew Simmons; Hemamalini Tirumalai; Céline Gélinas
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

3.  The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappaB that blocks TNFalpha-induced apoptosis.

Authors:  W X Zong; L C Edelstein; C Chen; J Bash; C Gélinas
Journal:  Genes Dev       Date:  1999-02-15       Impact factor: 11.361

4.  The bfl-1 gene is transcriptionally upregulated by the Epstein-Barr virus LMP1, and its expression promotes the survival of a Burkitt's lymphoma cell line.

Authors:  B D'Souza; M Rowe; D Walls
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

5.  Nuclear factor kappa B-dependent activation of the antiapoptotic bfl-1 gene by the Epstein-Barr virus latent membrane protein 1 and activated CD40 receptor.

Authors:  Brendan N D'Souza; Leonard C Edelstein; Pamela M Pegman; Sinéad M Smith; Sinéad T Loughran; Ann Clarke; Anja Mehl; Martin Rowe; Céline Gélinas; Dermot Walls
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

6.  Constitutively activated Akt-1 is vital for the survival of human monocyte-differentiated macrophages. Role of Mcl-1, independent of nuclear factor (NF)-kappaB, Bad, or caspase activation.

Authors:  H Liu; H Perlman; L J Pagliari; R M Pope
Journal:  J Exp Med       Date:  2001-07-16       Impact factor: 14.307

Review 7.  Partially corrected X-linked severe combined immunodeficiency: long-term problems and treatment options.

Authors:  Suk See De Ravin; Harry L Malech
Journal:  Immunol Res       Date:  2009       Impact factor: 4.505

8.  Upregulation of bfl-1 is a potential mechanism of chemoresistance in B-cell chronic lymphocytic leukaemia.

Authors:  A Olsson; M Norberg; A Okvist; K Derkow; A Choudhury; G Tobin; F Celsing; A Osterborg; R Rosenquist; M Jondal; L M Osorio
Journal:  Br J Cancer       Date:  2007-08-28       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.